|Articles|April 15, 2002
- BioPharm International-09-01-2002
- Volume 15
- Issue 9
Virus Inactivation in the 1990s ? and into the 21st Century Part 3a, Plasma and Plasma Products (Heat and Solvent/Detergent Treatments)
Author(s)Gail Sofer
by Gail Sofer, BioReliance Plasma products have been associated with high levels of risk from viral contamination; therefore, most viral inactivation methods described in the literature during the past ten years have addressed plasma and plasma products. Plasma is the largest group to cover, and Part 3 takes two articles in our series to describe the many methods published. This article covers heat and solvent/detergent inactivation treatments for plasma.
Advertisement
Articles in this issue
over 23 years ago
Reexamining the Set It and Forget It Approachover 23 years ago
Security in the Corporate Homelandover 23 years ago
Integrating New Technology into Blood Plasma Fractionationover 23 years ago
Attack Mounts on Pharmaceutical Pricesover 23 years ago
If a Tree Fell in the ForestNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
